Medical Properties Trust

Shares of Medical Properties Trust fell to a 52-week low of $3.96, leaving them down 11.78% year to date. In Q2 2026 revenue of $259.28 million beat expectations, but showed a small loss of $0.01 per share; normalized FFO remained stable at $0.15. The company plans the issuance of $2.4 billion of senior secured notes to refinance maturing debt; the stock offers a dividend yield of 8.8% and is rated below fair value by InvestingPro. » More on de.investing.com

Shares of Medical Properties Trust hit a new 52-week low of $3.99 and remain under sustained pressure; they are down 15.9% year-to-date and 21.7% over six months. The company completed a private placement and an exchange transaction that issued $2.4 billion of senior secured notes (maturing 2032) and refinanced about $1.5 billion of unsecured notes with maturities from 2027–2031. In the second quarter, revenue of $259.28 million beat expectations but showed a small loss of $0.01 per share; normalized FFO were $0.15 per share. Management reports progress on its refinancing plan to eliminate debt maturities through 2027; market capitalization is $2.39 billion with a dividend yield of 8.89%, and analysts see a possible return to profitability. » More on de.investing.com

Medical Properties Trust issued, in a private placement, $2.4 billion in senior secured notes due February 15, 2032, with a 9.25% coupon. Proceeds will be used to fully repay 2026 maturities and to partially redeem 2027 notes; in addition, about $1.5 billion of unsecured bonds were refinanced in a private exchange. The notes are secured by first- and second‑priority liens and guarantees, include covenants and change-of-control repurchase options; the transaction covers roughly 25% of the company’s total debt. » More on de.investing.com